http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012137503-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 |
| filingDate | 2011-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012137503-A |
| titleOfInvention | DRUG FOR TREATMENT AND / OR PREVENTION OF CANCER |
| abstract | 1. A medicament for treating and / or preventing cancer, comprising a combination of an antibody or fragment thereof having immunological reactivity to CAPRIN-1 protein and one or two or more types of antitumor agents, wherein the antibody or fragment and antitumor agent or antitumor agents are combined instead or used separately. 2. The medicament according to claim 1, wherein the antibody or fragment thereof having immunological reactivity with the CAPRIN-1 protein is an antibody or fragment thereof that specifically binds to the extracellular region of the CAPRIN-1 protein that exists on the surface of the cancer cell. . The medicament according to claim 1, wherein the antibody or fragment thereof having immunological reactivity with the CAPRIN-1 protein is an antibody or fragment thereof that specifically binds to a polypeptide having the amino acid sequence shown as SEQ ID NO: 37 , in the extracellular region of the CAPRIN-1 protein that exists on the surface of a malignant cell, or an amino acid sequence having 80% or higher sequence identity with the amino acid sequence as SEQ ID NO: 37.4. The medicament according to claim 1, wherein the CAPRIN-1 protein is a human protein. The medicament according to claim 1, wherein the aforementioned antitumor agent is any of the antitumor agents that are described in the description. The medicament according to claim 5, wherein the antitumor agent is selected from the group consisting of cyclophosphamide, paclitax |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9862774-B2 |
| priorityDate | 2010-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.